Antibiotic susceptibility patterns of isolates from children with urinary tract infection in Isfahan, Iran: Impact on empirical treatment

•E. coli was the most common cause of UTI among 364 isolates.•More than 50% of isolates were resistant to cotrimoxazole and cefalexin.•Only 53% of pathogens were susceptible to cefotaxime.•Susceptibility to nitrofurantoin, ciprofloxacin and imipenem was >70%.•Resistance to imipenem, cefotaxime an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of global antimicrobial resistance. 2017-06, Vol.9, p.3-7
Hauptverfasser: Karimian, Mahnaz, Kermani, Rasoul, Khaleghi, Moj, Kelishadi, Roya, Ataei, Behrooz, Mostafavi, Nasser
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 7
container_issue
container_start_page 3
container_title Journal of global antimicrobial resistance.
container_volume 9
creator Karimian, Mahnaz
Kermani, Rasoul
Khaleghi, Moj
Kelishadi, Roya
Ataei, Behrooz
Mostafavi, Nasser
description •E. coli was the most common cause of UTI among 364 isolates.•More than 50% of isolates were resistant to cotrimoxazole and cefalexin.•Only 53% of pathogens were susceptible to cefotaxime.•Susceptibility to nitrofurantoin, ciprofloxacin and imipenem was >70%.•Resistance to imipenem, cefotaxime and cefalexin was higher in recurrent UTI cases. The aim of this study was to identify the antibiotic susceptibility of bacteria causing urinary tract infections (UTIs) in children in Isfahan, Iran. Retrospective and prospective analyses were conducted on isolates from children with UTIs in a referral teaching hospital of Isfahan during 2013–2015. Findings were compared between first episode versus recurrent, nosocomial versus community-acquired, previous antibiotic use versus no previous antibiotic use, and febrile versus afebrile cases. Among 364 patients, 68.1% had no previous UTI, 19.7% has received antibiotics prior to infection and 96.2% were infected outside the hospital. Escherichia coli was the leading cause of UTI (68.1%), followed by Enterobacter (9.3%), Klebsiella (8.8%) and other bacteria (13.7%). Most isolates were relatively highly susceptible to imipenem (79.2%), ciprofloxacin (78.0%) and nitrofurantoin (70.8%), whereas sensitivity to cefotaxime (53%), cefalexin (39.8%) and trimethoprim/sulfamethoxazole (SXT) (26.1%) was low. Resistance to imipenem, cefotaxime and cefalexin was more prevalent in recurrent cases as well as in patients consuming antibiotics prior to UTI. Resistance of nosocomial cases to nitrofurantoin and cefotaxime was higher. In addition, afebrile patients had isolates that were more resistant to imipenem, ciprofloxacin and cefotaxime. Significant cross-resistance was found between most of the studied antibiotics. Urinary pathogens showed low susceptibility to cefalexin, SXT and cefotaxime and high susceptibility to imipenem, ciprofloxacin and nitrofurantoin. Therefore, use of imipenem and ciprofloxacin should be considered in hospitalised children with severe or complicated disease. In addition, nitrofurantoin is a good option in afebrile cases and for UTI chemoprophylaxis in this area.
doi_str_mv 10.1016/j.jgar.2016.12.014
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1872581447</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2213716517300267</els_id><sourcerecordid>1872581447</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-6bdf31e7d2f09c1ce0566164a6bd951cf3b39e76a1db9e3d754235c9094ec3fb3</originalsourceid><addsrcrecordid>eNp9UU1v1DAUtBCIVqV_gAPykQMb8uzE2SAuVcXHSpW4wNlynGf2rRI72A5VfwL_GkdbesQXz9ObGWneMPYa6gpqUO9P1emniZUouAJR1dA8Y5dCgNx10MnnT1i1F-w6pVNdXt-AUN1LdiH2Qgoh-kv258ZnGihksjytyeKyjRPlB76YnDH6xIPjlMJkMibuYpi5PdI0RvT8nvKRr5G8iQ88R2MzJ-_QZgq-IH5IzhyNf8cP0fgP_DAvG6XscF4okjVTUaHJM_r8ir1wZkp4_fhfsR-fP32__bq7-_blcHtzt7OyVXmnhtFJwG4Uru4tWKxbpUA1piz6FqyTg-yxUwbGoUc5dm0jZGv7Eh6tdIO8Ym_PvksMv1ZMWc9Uck-T8RjWpGHfiXYPTdMVqjhTbQwpRXR6iTSXrBpqvbWgT3prQW8taBC6tFBEbx7912HG8Uny7-aF8PFMwJLyN2HUyRJ6iyPFcjo9Bvqf_18cZZt9</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1872581447</pqid></control><display><type>article</type><title>Antibiotic susceptibility patterns of isolates from children with urinary tract infection in Isfahan, Iran: Impact on empirical treatment</title><source>Alma/SFX Local Collection</source><creator>Karimian, Mahnaz ; Kermani, Rasoul ; Khaleghi, Moj ; Kelishadi, Roya ; Ataei, Behrooz ; Mostafavi, Nasser</creator><creatorcontrib>Karimian, Mahnaz ; Kermani, Rasoul ; Khaleghi, Moj ; Kelishadi, Roya ; Ataei, Behrooz ; Mostafavi, Nasser</creatorcontrib><description>•E. coli was the most common cause of UTI among 364 isolates.•More than 50% of isolates were resistant to cotrimoxazole and cefalexin.•Only 53% of pathogens were susceptible to cefotaxime.•Susceptibility to nitrofurantoin, ciprofloxacin and imipenem was &gt;70%.•Resistance to imipenem, cefotaxime and cefalexin was higher in recurrent UTI cases. The aim of this study was to identify the antibiotic susceptibility of bacteria causing urinary tract infections (UTIs) in children in Isfahan, Iran. Retrospective and prospective analyses were conducted on isolates from children with UTIs in a referral teaching hospital of Isfahan during 2013–2015. Findings were compared between first episode versus recurrent, nosocomial versus community-acquired, previous antibiotic use versus no previous antibiotic use, and febrile versus afebrile cases. Among 364 patients, 68.1% had no previous UTI, 19.7% has received antibiotics prior to infection and 96.2% were infected outside the hospital. Escherichia coli was the leading cause of UTI (68.1%), followed by Enterobacter (9.3%), Klebsiella (8.8%) and other bacteria (13.7%). Most isolates were relatively highly susceptible to imipenem (79.2%), ciprofloxacin (78.0%) and nitrofurantoin (70.8%), whereas sensitivity to cefotaxime (53%), cefalexin (39.8%) and trimethoprim/sulfamethoxazole (SXT) (26.1%) was low. Resistance to imipenem, cefotaxime and cefalexin was more prevalent in recurrent cases as well as in patients consuming antibiotics prior to UTI. Resistance of nosocomial cases to nitrofurantoin and cefotaxime was higher. In addition, afebrile patients had isolates that were more resistant to imipenem, ciprofloxacin and cefotaxime. Significant cross-resistance was found between most of the studied antibiotics. Urinary pathogens showed low susceptibility to cefalexin, SXT and cefotaxime and high susceptibility to imipenem, ciprofloxacin and nitrofurantoin. Therefore, use of imipenem and ciprofloxacin should be considered in hospitalised children with severe or complicated disease. In addition, nitrofurantoin is a good option in afebrile cases and for UTI chemoprophylaxis in this area.</description><identifier>ISSN: 2213-7165</identifier><identifier>EISSN: 2213-7173</identifier><identifier>DOI: 10.1016/j.jgar.2016.12.014</identifier><identifier>PMID: 28232229</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Antimicrobial susceptibility ; Children ; Iran ; Pathogens ; Urinary tract infection</subject><ispartof>Journal of global antimicrobial resistance., 2017-06, Vol.9, p.3-7</ispartof><rights>2017 International Society for Chemotherapy of Infection and Cancer</rights><rights>Copyright © 2017 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-6bdf31e7d2f09c1ce0566164a6bd951cf3b39e76a1db9e3d754235c9094ec3fb3</citedby><cites>FETCH-LOGICAL-c356t-6bdf31e7d2f09c1ce0566164a6bd951cf3b39e76a1db9e3d754235c9094ec3fb3</cites><orcidid>0000-0002-3375-201X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28232229$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Karimian, Mahnaz</creatorcontrib><creatorcontrib>Kermani, Rasoul</creatorcontrib><creatorcontrib>Khaleghi, Moj</creatorcontrib><creatorcontrib>Kelishadi, Roya</creatorcontrib><creatorcontrib>Ataei, Behrooz</creatorcontrib><creatorcontrib>Mostafavi, Nasser</creatorcontrib><title>Antibiotic susceptibility patterns of isolates from children with urinary tract infection in Isfahan, Iran: Impact on empirical treatment</title><title>Journal of global antimicrobial resistance.</title><addtitle>J Glob Antimicrob Resist</addtitle><description>•E. coli was the most common cause of UTI among 364 isolates.•More than 50% of isolates were resistant to cotrimoxazole and cefalexin.•Only 53% of pathogens were susceptible to cefotaxime.•Susceptibility to nitrofurantoin, ciprofloxacin and imipenem was &gt;70%.•Resistance to imipenem, cefotaxime and cefalexin was higher in recurrent UTI cases. The aim of this study was to identify the antibiotic susceptibility of bacteria causing urinary tract infections (UTIs) in children in Isfahan, Iran. Retrospective and prospective analyses were conducted on isolates from children with UTIs in a referral teaching hospital of Isfahan during 2013–2015. Findings were compared between first episode versus recurrent, nosocomial versus community-acquired, previous antibiotic use versus no previous antibiotic use, and febrile versus afebrile cases. Among 364 patients, 68.1% had no previous UTI, 19.7% has received antibiotics prior to infection and 96.2% were infected outside the hospital. Escherichia coli was the leading cause of UTI (68.1%), followed by Enterobacter (9.3%), Klebsiella (8.8%) and other bacteria (13.7%). Most isolates were relatively highly susceptible to imipenem (79.2%), ciprofloxacin (78.0%) and nitrofurantoin (70.8%), whereas sensitivity to cefotaxime (53%), cefalexin (39.8%) and trimethoprim/sulfamethoxazole (SXT) (26.1%) was low. Resistance to imipenem, cefotaxime and cefalexin was more prevalent in recurrent cases as well as in patients consuming antibiotics prior to UTI. Resistance of nosocomial cases to nitrofurantoin and cefotaxime was higher. In addition, afebrile patients had isolates that were more resistant to imipenem, ciprofloxacin and cefotaxime. Significant cross-resistance was found between most of the studied antibiotics. Urinary pathogens showed low susceptibility to cefalexin, SXT and cefotaxime and high susceptibility to imipenem, ciprofloxacin and nitrofurantoin. Therefore, use of imipenem and ciprofloxacin should be considered in hospitalised children with severe or complicated disease. In addition, nitrofurantoin is a good option in afebrile cases and for UTI chemoprophylaxis in this area.</description><subject>Antimicrobial susceptibility</subject><subject>Children</subject><subject>Iran</subject><subject>Pathogens</subject><subject>Urinary tract infection</subject><issn>2213-7165</issn><issn>2213-7173</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9UU1v1DAUtBCIVqV_gAPykQMb8uzE2SAuVcXHSpW4wNlynGf2rRI72A5VfwL_GkdbesQXz9ObGWneMPYa6gpqUO9P1emniZUouAJR1dA8Y5dCgNx10MnnT1i1F-w6pVNdXt-AUN1LdiH2Qgoh-kv258ZnGihksjytyeKyjRPlB76YnDH6xIPjlMJkMibuYpi5PdI0RvT8nvKRr5G8iQ88R2MzJ-_QZgq-IH5IzhyNf8cP0fgP_DAvG6XscF4okjVTUaHJM_r8ir1wZkp4_fhfsR-fP32__bq7-_blcHtzt7OyVXmnhtFJwG4Uru4tWKxbpUA1piz6FqyTg-yxUwbGoUc5dm0jZGv7Eh6tdIO8Ym_PvksMv1ZMWc9Uck-T8RjWpGHfiXYPTdMVqjhTbQwpRXR6iTSXrBpqvbWgT3prQW8taBC6tFBEbx7912HG8Uny7-aF8PFMwJLyN2HUyRJ6iyPFcjo9Bvqf_18cZZt9</recordid><startdate>201706</startdate><enddate>201706</enddate><creator>Karimian, Mahnaz</creator><creator>Kermani, Rasoul</creator><creator>Khaleghi, Moj</creator><creator>Kelishadi, Roya</creator><creator>Ataei, Behrooz</creator><creator>Mostafavi, Nasser</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3375-201X</orcidid></search><sort><creationdate>201706</creationdate><title>Antibiotic susceptibility patterns of isolates from children with urinary tract infection in Isfahan, Iran: Impact on empirical treatment</title><author>Karimian, Mahnaz ; Kermani, Rasoul ; Khaleghi, Moj ; Kelishadi, Roya ; Ataei, Behrooz ; Mostafavi, Nasser</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-6bdf31e7d2f09c1ce0566164a6bd951cf3b39e76a1db9e3d754235c9094ec3fb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Antimicrobial susceptibility</topic><topic>Children</topic><topic>Iran</topic><topic>Pathogens</topic><topic>Urinary tract infection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Karimian, Mahnaz</creatorcontrib><creatorcontrib>Kermani, Rasoul</creatorcontrib><creatorcontrib>Khaleghi, Moj</creatorcontrib><creatorcontrib>Kelishadi, Roya</creatorcontrib><creatorcontrib>Ataei, Behrooz</creatorcontrib><creatorcontrib>Mostafavi, Nasser</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of global antimicrobial resistance.</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Karimian, Mahnaz</au><au>Kermani, Rasoul</au><au>Khaleghi, Moj</au><au>Kelishadi, Roya</au><au>Ataei, Behrooz</au><au>Mostafavi, Nasser</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antibiotic susceptibility patterns of isolates from children with urinary tract infection in Isfahan, Iran: Impact on empirical treatment</atitle><jtitle>Journal of global antimicrobial resistance.</jtitle><addtitle>J Glob Antimicrob Resist</addtitle><date>2017-06</date><risdate>2017</risdate><volume>9</volume><spage>3</spage><epage>7</epage><pages>3-7</pages><issn>2213-7165</issn><eissn>2213-7173</eissn><abstract>•E. coli was the most common cause of UTI among 364 isolates.•More than 50% of isolates were resistant to cotrimoxazole and cefalexin.•Only 53% of pathogens were susceptible to cefotaxime.•Susceptibility to nitrofurantoin, ciprofloxacin and imipenem was &gt;70%.•Resistance to imipenem, cefotaxime and cefalexin was higher in recurrent UTI cases. The aim of this study was to identify the antibiotic susceptibility of bacteria causing urinary tract infections (UTIs) in children in Isfahan, Iran. Retrospective and prospective analyses were conducted on isolates from children with UTIs in a referral teaching hospital of Isfahan during 2013–2015. Findings were compared between first episode versus recurrent, nosocomial versus community-acquired, previous antibiotic use versus no previous antibiotic use, and febrile versus afebrile cases. Among 364 patients, 68.1% had no previous UTI, 19.7% has received antibiotics prior to infection and 96.2% were infected outside the hospital. Escherichia coli was the leading cause of UTI (68.1%), followed by Enterobacter (9.3%), Klebsiella (8.8%) and other bacteria (13.7%). Most isolates were relatively highly susceptible to imipenem (79.2%), ciprofloxacin (78.0%) and nitrofurantoin (70.8%), whereas sensitivity to cefotaxime (53%), cefalexin (39.8%) and trimethoprim/sulfamethoxazole (SXT) (26.1%) was low. Resistance to imipenem, cefotaxime and cefalexin was more prevalent in recurrent cases as well as in patients consuming antibiotics prior to UTI. Resistance of nosocomial cases to nitrofurantoin and cefotaxime was higher. In addition, afebrile patients had isolates that were more resistant to imipenem, ciprofloxacin and cefotaxime. Significant cross-resistance was found between most of the studied antibiotics. Urinary pathogens showed low susceptibility to cefalexin, SXT and cefotaxime and high susceptibility to imipenem, ciprofloxacin and nitrofurantoin. Therefore, use of imipenem and ciprofloxacin should be considered in hospitalised children with severe or complicated disease. In addition, nitrofurantoin is a good option in afebrile cases and for UTI chemoprophylaxis in this area.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>28232229</pmid><doi>10.1016/j.jgar.2016.12.014</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0002-3375-201X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 2213-7165
ispartof Journal of global antimicrobial resistance., 2017-06, Vol.9, p.3-7
issn 2213-7165
2213-7173
language eng
recordid cdi_proquest_miscellaneous_1872581447
source Alma/SFX Local Collection
subjects Antimicrobial susceptibility
Children
Iran
Pathogens
Urinary tract infection
title Antibiotic susceptibility patterns of isolates from children with urinary tract infection in Isfahan, Iran: Impact on empirical treatment
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T17%3A11%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antibiotic%20susceptibility%20patterns%20of%20isolates%20from%20children%20with%20urinary%20tract%20infection%20in%20Isfahan,%20Iran:%20Impact%20on%20empirical%20treatment&rft.jtitle=Journal%20of%20global%20antimicrobial%20resistance.&rft.au=Karimian,%20Mahnaz&rft.date=2017-06&rft.volume=9&rft.spage=3&rft.epage=7&rft.pages=3-7&rft.issn=2213-7165&rft.eissn=2213-7173&rft_id=info:doi/10.1016/j.jgar.2016.12.014&rft_dat=%3Cproquest_cross%3E1872581447%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1872581447&rft_id=info:pmid/28232229&rft_els_id=S2213716517300267&rfr_iscdi=true